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Abstract  Background: Salmonella enterica serovar Typhi (S. Typhi) is a human-specific pathogen that causes 
typhoid fever. Typhoid fever remains a global health problem especially in developing countries. Pathogenesis of 
typhoid fever is complex and host response is poorly understood.There is an urgent need for adequate and efficient 
detection methods for the establishment of carrierstate of typhoid fever as a source of transmission. We compared 
IgG anti-flagellar antibody and fagellin gene variants of S. Typhi to explore risks factor of typhoid fever carriers. 
Method: Serum and fecal swab samples obtained from 379 suspected for typhoid carrier. Typhoid carriers were 
identified when home visits of patients who have recovered from typhoid fever at least 1 year.In-house indirect 
sandwich ELISA were established to detect anti-flagellum IgG.DNA Samples obtained directly from fecal swab 
were confirmed to be serovar Typhi by nested PCR. All specimens were examined for their Hd, Hj, z66 and z66 Ind 
flagellin genes by Polymerase Chain Reaction (PCR). Results: A total of 379 suspected patients, where examined 
by nested PCR to detect specific flagellin gene for S. typhi, and found 21 (5.28%) samples were positive. Serum 
samples from all suspected typhoid carrier were examined by ELISA to detect titer of anti-flagellum IgG. Of 21 
typhoid carrier patients, there were 2 (9.5%) patients had Hd+ variant; one (4.8%) patient had Hj+ variant; 6 (28.6%) 
patients had Hd+Z66+ variant; one (4.8%) patient had Hj+ Z66+ variant and 11 (52.3%) patients had Hd+Z66IND+ 
variant. There were 34 patients positive for anti-flagellum IgG antibody after examine by ELISA. Among PCR 
positive patients there were 14 patients had high titer and 7 patients had low titer of anti-flagellum IgG antibody. 
Within PCR negative we found 13 patients with low titer of anti-flagellum IgG. Conclusions: We conclude that 
patient harboring Hd+Z66IND+ gene of S. Typhi and High titer of IgG antibody anti-flagellum S. Typhi considered 
to be risk factor for typhoid carriers development. 
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1. Background 
Typhoid fever is a systemic infection in human that is 
caused by Salmonella enterica subsp. enterica serovar 
Typhi (S. Typhi) [1]. It is a febrile, systemic illness 
commonly affected human in areas where sanitation is 
poor [2]. S. Typhi is responsible for 21.7 million 
infections and cause death for approximately 217,000 
peoples worldwide annually [3]. In Sulawesi, Indonesia, 
typhoid fever is one of the most frequent infectious 
diseases [4]. Three to five percent of enteric fever become 
chronic carriers and harbour S. Typhi throughout their 
lifetime [5]. Typhoid fever is spread primarily through 
fecal contamination of food and drinking water from 
patients or carriers [6]. 
Pathogenesis of typhoid fever is complex and host 
response is poorly understood [7]. Some early studies 
have revealed relationship between flagellar function as 
determined by motility, and invasiveness in Salmonella 
species [8]. Flagella of Salmonella are expressed on the 
cell surface, they consist of a basal body embedded in the 
cell membrane, a central rod attached to a hook which in 
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turn attaches to a helical filament made up of polymerised 
units of flagellin protein [9,10]. Currently, we identified a 
new ﬂagellin gene that encoded the z66 Ind gene. The z66 
gene was present in 15.4% of isolates and this “foreign” 
flagellin gene was associated with increasing risk of 
severe clinical symptoms [11]. 
There is an urgent need for adequate and efficient 
detection methods for the establishment of carrier state of 
typhoid fever, perhaps based on genomic markers such as 
flagellin gene and immunological response of host such as 
titer of IgG anti-flagellum. In this study, we compared IgG 
anti-flagellar antibody and fagellin gene variants of S. 
Typhi to explore risks factor of typhoid fever carriers. 
2. Method 
2.1. Clinical Specimens 
Serum and fecal swab samples obtained from 379 
suspected for typhoid carrier. Typhoid carriers were 
identified when home visits of patients who have 
recovered from typhoid fever at least 1 year. DNA 
Samples obtained directly from fecal swab were 
confirmed to be serovar Typhi by nested PCR. This study 
was approved by the ethical boards of the participating 
institutes and informed consents were obtained from all 
participants or from their parents/guardians. 
2.2. Serologic Analysis  
In-house indirect sandwich ELISA were established to 
detectanti-flagellum IgG. Flat-bottom 96-well 
microtiterplates were coated overnight at 4°C with 100 µl 
of either 1 µg of antigen/ml in coating buffer (0.1 
Mcarbonate buffer [pH 9.4], antigen positive) or coating 
buffer alone (antigen negative). Purified flagellum antigen 
of S. Typhi provided from Wellcome Trust Clinical 
Research Unit, United Kingdom. The plates were blocked 
for 1 hat 37°C with 200 µl of phosphate buffered saline 
containing 1% bovine serum albumin (BSA). Sera were 
either assayed in serially diluted (starting at adilution of 
1/50). Sera were diluted in phosphate-buffered saline 
containing 0.1% BSA and 0.05% Tween 20, 100 µl was 
applied to the appropriate wells, and the plates were 
incubated for 4 hat room temperature. Bound antibody 
(IgG) were detected using heavy-chain-specific goat 
antibodies directly conjugated to alkaline phosphatase. 
One hundred microliters was added to each well, and the 
plates were incubated overnight at 4°C. One hundred 
microliters of p-nitrophenyl phosphate (1 mg/ml) was 
added to each well, and the plates were incubated at 
ambient temperature in the dark for 30 to 40 min. The 
absorbance at 405 nm (reference filter, 450 nm) was 
determined using an automated ELISA reader. For sera 
assayed at a single dilution, antibody levels were 
expressed in optical density (OD) units. These were taken 
as the mean OD of three wells with antigen minus the OD 
of a single well without antigen. For the titration assays, 
sera were assayed in triplicate (two wells antigen positive 
and one well antigen negative), and the titer was taken as 
the highest dilution giving a net OD (mean OD of antigen-
positive wells minus OD of antigen-negative well) of ≥0.2. 
Six standards were included on each plate, and the OD or 
titer of the samples was adjusted accordingly. Blank wells 
with nosera were included to monitor background [12]. 
We estimated the high titer of IgG anti-flagellum in 
endemic area of typhoid fever were ≥1/200 and Low titer 
<1/200 according to House et al. [12]. 
2.3. Preparation of DNA 
DNA was extracted from fecal swab samples according 
to the diatom-guanidinium isothiocyanate (GuSCN) 
method. For the preparation of DNA from feces, a stool 
sample with a volume of approximately 100 uL was 
attached to a cotton swab, suspended in 1 mL of sterile 
water, vortexed vigorously, and centrifuged at 1,000 rpm 
for 5 min and added in 900 uL of lysis buffer (50 mM 
Tris-HCl, 5.25 M GuSCN, 20 mM EDTA, 0.1% Triton X-
100) and centrifuged at 12,000 × g for 10 minutes. To 
obtain the DNA, samples were lysed by incubation for 15 
minutes at 18°C and 20 uL of diatom suspension was 
added. The diatom containing the bound DNA was 
sedimented by centrifugation at 12,000 × g for 15 seconds. 
The diatom pellet was washed with washing buffer (5.25 
M GuSCN in 0.1 M Tris-HCl, pH 6.4), rinsed with 70% 
ethanol and acetone, and dried by incubation at 56°C for 
10 minutes. The pellet was mixed with 60 uLof 10 mM 
Tris-HCl, pH 8.0, 1 mM EDTA buffer and the DNA was 
eluted by incubation at 56°C for 10 minutes. After 
sedimentation of the diatom by centrifugation, the 
supernatant was collected and stored at -20°C until PCR 
was performed [13]. 
2.4. Amplification of Flagellin Genes 
The fliC primers set for the fliC genes amplification, 
which will give a result of around 1500 bp for the H:d 
antigen or about 200 bp smaller for the H:j antigen. The 
final set is for the z66 antigen, which will give a product 
of about 1500 bp if the strains are z66+, and will give no 
result if they are z66- [14]. Amplification of fliC gene was 
performed using primers: fliCF: 
TTAACGCAGTAAAGAGAG and fliC_R: 
ATGGCACAAGTCATTAATAC and produce a 1521 bp 
product for the d allele and a 1273 bp product for the j 
allele. Amplification of the fljBz66 was performed as 
previously described using z66Flag_F: 
TGGCACAAGTCATCAATAC and z66Flag_R: 
TTAACGCAGCAGAGACAGTAC. Control PCR 
amplicons from the aroC gene were produced using 
primers aroCfor: CCTGGCACCTCGCGCTATAC and 
aroCrev: CCACACACGGATCGTGGCG. Primers 
position on chromosome fliC_F 2011173 and fliC_R 
2012674; aroC_F 2450480 and aroC_R 2449674. The 
other primers are on a plasmid. Cycles is consist of an 
initial denaturation at 94°C for 1 min, 30 cycle at 94°C for 
30 s, 57°C for 30 s, and 72°C for 2 min, followed by an 
extension step of 72°C for 2 min [14]. For z66Ind primer 
set designated Ind-F:5' ATG TCG GAA ATC AAC CGT 
ATC T 3' and Ind-R:5' CAG GCC GTC AAC CTG AGA 
C 3' were selected for the specific amplification of a 597 
bp segment of the Ind gene. The PZ66-A and PZ66-B 
primers are located in the central region of the z66 gene 
that is largely deleted in the Ind gene and the primers Ind-
F and Ind-R are located in the 5' and 3' portion of the Ind 
gene that shows homology with the z66 gene, but these 
primers are chosen such that the number of mismatches 
with this gene is too high to warrant efficient 
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amplification of the z66 gene [11,15]. The Ind-specific 
PCR was performed with after an initial denaturation at 
94°C for 2 min, for 35 cycles at 94°C for 30 s, 55°C for 30 
s, and 72°C for 1 min, followed by an extension step of 
72°C for 5 min [11].  
2.5. Statistical Analysis 
All statistical calculations were performed using the 
computer program EPI Info Version 6.0. The statistical 
data between 2 groups were tested by Fischer exact test. 
Considered significant when p value ≤0.05. 
3. Results 
3.1. Flagellin Genes Variants and Anti-
Flagellum IgG titer in Typhoid Fever Carrier 
Suspects 
 
Figure 1. Flowchart of detection of cariers state, flagellingene variants 
and IgG results 
Figure 1. showed the number of samples recorded from 
primary health care center and hospital. A total of 379 
suspected patients, where examined by nested PCR to 
detect specific flagellin gene for S. typhi, and found 21 
(5.28%) samples were positive. Serum samples from all 
suspected typhoid carrier were examined by ELISA to 
detect titer of anti-flagellum IgG. Of 21 typhoid carrier 
patients, there were 2 (9.5%) patients had Hd+ variant; 
one (4.8%) patient had Hj+ variant; 6 (28.6%) patients had 
Hd+Z66+ variant; one (4.8%) patient had Hj+ Z66+ 
variant and 11 (52.3%) patients had Hd+Z66IND+ variant. 
There were 34 patients positive for anti-flagellum IgG 
antibody after examine by ELISA. Among PCR positive 
patients there were 14 patients had high titer and 7 patients 
had low titer of anti-flagellum IgG antibody. Within PCR 
negative we found 13 patients with low titer of anti-
flagellum IgG. Thus, we exclude this samples from our 
study to focus only in typhoid carriers. 
3.2. Flagellin Genes Variantsof S. typhiin 
Typhoid Carrier Patients  
Flagellin gene variants S. typhi of typhoid carrier 
patients shown in Figure 2., Hd+Z66+ shown as 1500 bp 
band (Hd+ = 1500 bp and Z66+=1500 bp) and AroC+ act 
as amplicon control 800 bp band (lane 2). Variation in 
flagellin gene Hj+Z66+ shown as 1200 bp and 1500 bp 
band (Hj+ = 1200 bp and Z66+=1500 bp) and 800 bp of 
AroC+ as amplicon control (lane 3). In lane 4, AroC+ 800 
bp band as control. 
 
Figure 2. Electrophoresis gel results of flagellin gene variants S.typhiin 
carriers states of typhoid fever 
Note:  
Lane 1: Marker 100 bp 
Lane 2: Hd+z66+; 1500 bp (Hd+), 1500 bp (z66+ ) and 
800 bp (AroC+ for control) 
Lane 3 : Hj+z66+: 1200 bp (Hj+); 1500 bp (z66+) and 
800 bp (AroC+ for control) 
Lane 4: AroC+: 800 bp (AroC+ for control) 
Lane 5: Hd+: 1500 bp (Hd+) and 800 bp (AroC+ for 
control) 
Lane 6: Hj+: 1200 bp (Hj+) and 800 bp (AroC+ for 
control) 
Lane 7: z66+: 1500 bp (z66+) and 800 bp (AroC+ for 
control) 
Lane 8: z66IND+: 600 bp (z66IND+) 
Lane 9: Negative control 
4. Discussion 
In previous study, we have been reported that the Ind 
gene was detected in 21.8% of the S.typhi isolates from 
East Indonesian archipelago, all of which contained the 
Hd. The z66 gene was present in 15.4% of the isolates. 
Also, in our previous study shows that variant of 
Hd+Z66IND+ predominant in carrier state compared with 
acute typhoid patients (47.8% vs. 27.7%) [16]. 
The presence of these “foreign” flagellin genes could be 
associated with an increased risk for developing severe 
disease [11]. Furthermore, In this study we did not find a 
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significantly difference in percentage of positive Hj+, z66+, 
Hd+z66+, and Hj+z66+ of flagellin genes variant between 
the acute and the carriers state of typhoid fever. In contrast, 
Hd+, z66Ind+, Hd+z66Ind+, and Hj+z66Ind+ of flagellin 
genes variant was found strongly associated with carriers 
state of typhoid fever compared with acute illness. This 
finding indicates the possibility that S. typhi containing 
Hd+ and z66Ind+ of flagellin genes variants are more 
motile and more pathogenic compared with other S. typhi 
isolates. Our results demonstrate that ELISA provides 
significant result that high titer on IgG anti-flagellum 
antibody more prevalent in patients who have 
Hd+Z66IND+ variant compared to other variants (10/11 or 
90.9% vs 4/10 or 40%, Fisher exact test p value : <0.05). 
The relative predominant of certain variant of flagellin 
genes circulating in different endemic regions are still not 
been fully understood. An in-depth analysis of the host-
pathogen interactions and their influence on gallbladder 
microorganisms maybe able to explain the adaptation and 
persistence mechanisms of certain strain in carrier state. 
Unfortunately, they are still less reliable considering the 
fact that in the carriers, bacteria are shed intermittently. 
Thus, there is an urgent need for adequate and efficient 
detection methods for the establishment of carrier state of 
typhoid fever, perhaps based on genomic markers such as 
flagellin gene. In this study, titers of IgG antibodies to the 
flagellum antigens raised following exposure to 
Salmonella serotype Typhi harboring Hd+Z66IND+ gene 
among carriers state typhoid fever patients, and this fact 
presumably contributes as risk factor to develop typhoid 
fever carrier in regions of typhoid endemicity. Carrier 
state of typhoid fever is extremely important to prevent 
the transmission of these diseases. Previously many 
reports describe the persistence of positive S. Typhi 
among this asymptomatic state of typhoid fever by using 
conventional methods such as bacterial culture of faecal or 
urine samples. Although high titer of IgG in patient 
harboring Hd+Z66IND+ gene of S. Typhi, this antibody 
insufficient to eliminate the pathogen, it suggests that the 
immunity in this state to be incomplete [17]. Consistent 
with other study demonstrated that titers of IgG-class 
antibodies to the flagellum antigens can be raised 
following exposure to serotype Typhi [18]. We found 13 
patients with positive IgG anti-flagellum in low titer 
(<1/200) but negative PCR. These patients considered to 
be non carrier subjects. Therefore, we exclude these 
samples from our study. It could be argued that the serum 
anti-flagellum antibody titers seen in the sera of 13 
subjects were due to current or recent exposure with 
serotype Typhi, it is common in endemic areas such as in 
Indonesia. 
Table 1. The comparison between flagellin gene variants and anti-flagellum IgG titer in carriers state of typhoid fever 
Flagellin gene variants High and low of IgG antibody titer (percentage) p value High titer Low titer 
Hd+z66IND+ (n= 11) 10 (90.9) 1 (9.1) 
p <0.05* Others (n= 10) 
Hd+ 
4 (40) 6 (60) Hj+ Hd+z66+ 
Hj+z66+ 
Total (n=21) 14 (66.7) 7 (33.3) 
*Fisher exact test 
5. Conclusions 
We conclude that patient harboring Hd+Z66IND+ gene 
of S. Typhi and High titer of IgG antibody anti-flagellum 
S. Typhi considered to be risk factor for typhoid carriers 
development. 
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